Literature DB >> 1965910

Protective effects of andrographis paniculata nees on post-infarction myocardium in experimental dogs.

H Y Zhao1, W Y Fang.   

Abstract

One hour after the development of myocardial infarction by formation of thrombus, watery extract of Andrographis paniculata Nees (APN) was injected intravenously to 7 dogs for observing the protective effect of this drug on ischemic myocardium, 6 dogs served as control group. In the treated group PGI2 increased remarkably, synthesis of TXA2 was inhibited, cAMP in platelets was elevated, CK-MB peak was lowered and appeared earlier, ELT was shortened, release of platelet beta-GT was decreased, platelet maximum aggregation rate was inhibited, the size of ischemic area recorded by epicardial ECG was reduced, the amplitude of ST segment elevation was lower than that in the control group, Q wave appeared in only one dog. Pathologically, the myocardial structure surrounding the initially appearing ischemic area, i.e, the reversibly damaged area, became relatively normal, while the degree of myocardial degeneration and necrosis in the central part of the ischemic area was mild. These data suggest that APN may limit the expansion of ischemic focus, exert marked protective effect on reversibly ischemic myocardium and demonstrate a weak fibrinolytic action.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965910     DOI: 10.1007/bf02887933

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  8 in total

1.  A trial of dipyridamole and aspirin in the prevention of smoking-induced changes in platelets and endothelium in men with coronary artery disease.

Authors:  J W Davis; C R Hartman; L Shelton; H A Ruttinger
Journal:  Am J Cardiol       Date:  1989-06-15       Impact factor: 2.778

2.  Study on experimental model of coronary artery thrombogenesis and acute myocardial infarction: changes in epicardial ECG, platelet function and biochemistry, and pathology.

Authors:  W Y Fang; H Y Zhao
Journal:  J Tongji Med Univ       Date:  1989

3.  Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion.

Authors:  M Chiariello; P Golino; M Cappelli-Bigazzi; G Ambrosio; I Tritto; M Salvatore
Journal:  Am Heart J       Date:  1988-03       Impact factor: 4.749

Review 4.  Pharmacology of platelet-affecting drugs.

Authors:  M A Packham; J F Mustard
Journal:  Circulation       Date:  1980-12       Impact factor: 29.690

5.  Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.

Authors:  J Mehta
Journal:  JAMA       Date:  1983-05-27       Impact factor: 56.272

6.  Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.

Authors:  A M Bhat; H Sacks; J A Osborne; A M Lefer
Journal:  Am Heart J       Date:  1989-04       Impact factor: 4.749

7.  Treatment of reperfusion injury with intracoronary calcium channel antagonists and reduced coronary free calcium concentration in regionally ischemic, reperfused porcine hearts.

Authors:  H H Klein; S Pich; S Lindert; K Nebendahl; G Warneke; H Kreuzer
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

8.  Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.

Authors:  P Golino; J H Ashton; J McNatt; P Glas-Greenwalt; S K Yao; R A O'Brien; L M Buja; J T Willerson
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

  8 in total
  3 in total

Review 1.  A review on the molecular basis underlying the protective effects of Andrographis paniculata and andrographolide against myocardial injury.

Authors:  Sok Kuan Wong; Kok-Yong Chin; Soelaiman Ima-Nirwana
Journal:  Drug Des Devel Ther       Date:  2021-11-10       Impact factor: 4.162

2.  Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent Andrographolide.

Authors:  Thanasekaran Jayakumar; Cheng-Ying Hsieh; Jie-Jen Lee; Joen-Rong Sheu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

Review 3.  Andrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology.

Authors:  Md Sanower Hossain; Zannat Urbi; Abubakar Sule; K M Hafizur Rahman
Journal:  ScientificWorldJournal       Date:  2014-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.